Shenzhen Arimab Biopharmaceuticals Overview

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

Shenzhen Arimab Biopharmaceuticals General Information

Description

Developer of monoclonal antibody therapies in China. The company is engaged in the development and marketing of monoclonal antibody therapies

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Shenzhen, Guangdong
  • China
Primary Industry
Other Healthcare Services
Other Industries
Therapeutic Devices
Vertical(s)
Life Sciences
Corporate Office
  • Shenzhen, Guangdong
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shenzhen Arimab Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Shenzhen Arimab Biopharmaceuticals‘s full profile, request access.

Request a free trial

Shenzhen Arimab Biopharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Shenzhen Arimab Biopharmaceuticals‘s full profile, request access.

Request a free trial

Shenzhen Arimab Biopharmaceuticals FAQs

  • Where is Shenzhen Arimab Biopharmaceuticals headquartered?

    Shenzhen Arimab Biopharmaceuticals is headquartered in Shenzhen, China.

  • What industry is Shenzhen Arimab Biopharmaceuticals in?

    Shenzhen Arimab Biopharmaceuticals’s primary industry is Other Healthcare Services.

  • Is Shenzhen Arimab Biopharmaceuticals a private or public company?

    Shenzhen Arimab Biopharmaceuticals is a Private company.

  • What is Shenzhen Arimab Biopharmaceuticals’s current revenue?

    The current revenue for Shenzhen Arimab Biopharmaceuticals is .

  • Who are Shenzhen Arimab Biopharmaceuticals’s investors?

    Aridis Pharmaceuticals and Shenzhen Hepalink Pharmaceutical Group have invested in Shenzhen Arimab Biopharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process